Pain News and Research

Latest Pain News and Research

Exercise training safe in heart failure patients - offer clinical benefit

Exercise training is safe in heart failure patients, does not significantly reduce hospitalization or death, but is associated with several improved clinical outcomes, even in those already receiving optimal medical care, researchers reported at the American Heart Association's Scientific Sessions 2008. The Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) was presented as a late-breaking clinical trial.

11 Nov 2008

Chronic pain makes many sufferers contemplate suicide

According to new research patients suffering chronic pain are more likely than others to consider suicide.

11 Nov 2008

Study looks at sexual and intimate relationships after breast cancer

An Indiana University study found that young, female breast cancer survivors often suffer from sexual and intimate relationship issues and are interested in using sexual enhancement products to treat these problems.

11 Nov 2008

Secondary prevention program may reduce risks after heart attack

An intensive, comprehensive, long-term secondary prevention program lasting up to three years after cardiac rehabilitation appears to reduce the risk of a second non-fatal heart attack and other cardiovascular events, according to a report in the November 10 issue of Archives of Internal Medicine , one of the JAMA/Archives journals.

11 Nov 2008

Latest research on diagnosis and treatment of allergic diseases

Researchers are presenting more than 450 abstracts on investigational findings in the diagnosis and treatment of allergic diseases at the ACAAI Annual Meeting in Seattle, Nov. 6-11. Following are highlights of some key studies on asthma.

11 Nov 2008

Epstein-Barr virus linked to inflammatory diseases of the mouth

Researchers at Oregon Health & Science University's School of Dentistry have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus.

11 Nov 2008

Diabetes and foot problems

Bradford Miller has had diabetes for nine years, and he knows the importance of quick treatment for related problems such as swelling and numbness in the feet.

11 Nov 2008

Rheumatoid arthritis drugs too slow to stop damage

A study by New Zealand researchers has questioned the current treatment approaches for rheumatoid arthritis and say they may be too slow in controlling the start of the joint damage the disease causes.

10 Nov 2008

VIA Pharmaceuticals announces results of phase 2 trials of VIA-2291 in cardiovascular disease

VIA Pharmaceuticals, Inc. has announced the results of two Phase 2 studies of its lead drug, VIA-2291.

10 Nov 2008

Heart attack prevention within three months after hospitalization significantly averted future attacks

Despite substantial progress in the diagnosis and treatment of heart attack patients, prevention of recurrent heart attacks continues to be a major clinical challenge.

10 Nov 2008

Five key proteins form new, early-warning blood test before heart attack strikes

A team of Johns Hopkins biochemists has identified a mixed bag of five key proteins out of thousands secreted into blood draining from the heart's blood vessels that may together or in certain quantities form the basis of a far more accurate early warning test than currently in use of impending heart attack in people with severely reduced blood flow, or ischemia.

10 Nov 2008

Crestor (rosuvastatin calcium) shown to significantly reduce major cardiovascular events

New data from the JUPITER study demonstrated that Crestor (rosuvastatin calcium) 20 mg significantly reduced major cardiovascular (CV) events (defined in this study as the combined risk of myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from CV causes) by a dramatic 44% compared to placebo (p<0.001) among men and women with elevated hsCRP but low to normal cholesterol levels.

10 Nov 2008

Bullies love to bully

The researchers from the University of Chicago used functional Magnetic Resonance Imaging (fMRI) scans of eight 16 to 18 year-old boys with aggressive conduct disorder and compared them to eight matched adolescents without conduct disorder.

9 Nov 2008

Scientists on a quest to find the right prescription for exercise

Canadian scientists have a plan in the pipeline to explore just why exercise is so beneficial to the body.

9 Nov 2008

Pycnogenol cuts jetlag in half

Scientists have found that Pycnogenol, a natural plant extract from the bark of pine trees, can reduce jetlag symptoms by half. Pycnogenol is the patented trade name for a water extract of the bark of the French maritime pine (Pinus pinaster ssp. atlantica), which is grown in coastal southwest France.

9 Nov 2008

We all know physical activity is good for you. But why exactly is it good for you?

What effect does exercise have on the cells and tissues of the body? What do we need to know so that we can use physical activity more effectively to combat chronic diseases such as arthritis, diabetes and heart disease? And what social and psychological factors prevent people from exercising or playing sports?

8 Nov 2008

Brain scans show bullies may enjoy seeing others in pain

Unusually aggressive youth may actually enjoy inflicting pain on others, research using brain scans at the University of Chicago shows.

8 Nov 2008

Improving quality of life after breast cancer treatment

Opting for less damaging treatments, staying active and learning about the warning signs of lymphedema: that's how women with breast cancer can avoid developing chronic lymphedema, according to the German Institute for Quality and Efficiency in Health Care (IQWiG).

7 Nov 2008

FDA approves Ranexa for the treatment of chronic angina

CV Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved a new, first line indication for Ranexa(R) (ranolazine extended-release tablets) for the treatment of chronic angina.

7 Nov 2008

Saw Palmetto for enlarged prostate

Physician-scientists are studying an herbal supplement that might aid in reducing the symptoms of an enlarged prostate in men. Recent figures show that benign prostatic hyperplasia (BPH) occurs in an estimated 50 percent of men over the age of 50 and in 75 percent of men 80 and older.

6 Nov 2008

Pain News and Research

Latest Pain News and Research

Exercise training safe in heart failure patients - offer clinical benefit

Chronic pain makes many sufferers contemplate suicide

Study looks at sexual and intimate relationships after breast cancer

Secondary prevention program may reduce risks after heart attack

Latest research on diagnosis and treatment of allergic diseases

Epstein-Barr virus linked to inflammatory diseases of the mouth

Diabetes and foot problems

Rheumatoid arthritis drugs too slow to stop damage

VIA Pharmaceuticals announces results of phase 2 trials of VIA-2291 in cardiovascular disease

Heart attack prevention within three months after hospitalization significantly averted future attacks

Five key proteins form new, early-warning blood test before heart attack strikes

Crestor (rosuvastatin calcium) shown to significantly reduce major cardiovascular events

Bullies love to bully

Scientists on a quest to find the right prescription for exercise

Pycnogenol cuts jetlag in half

We all know physical activity is good for you. But why exactly is it good for you?

Brain scans show bullies may enjoy seeing others in pain

Improving quality of life after breast cancer treatment

FDA approves Ranexa for the treatment of chronic angina

Saw Palmetto for enlarged prostate

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Pain News and Research

Latest Pain News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in